Eric Lander Active in First Few Weeks as OSTP Director; Community Awaits PCAST Appointments

In the first few weeks since his confirmation on May 28, Director of the White House Office of Science and Technology Policy (OSTP) Eric Lander has been active in advocating for President Biden’s ambitious science policy agenda, most notably the proposal for the Advanced Research Projects Agency for Health (ARPA-H), the DARPA-like research agency proposed to be housed within the National Institutes of Health (NIH). During the June 10-11 meeting of the Advisory Committee to the Director of NIH, Lander presented a more thorough vision of ARPA-H’s role as a high risk, high reward vehicle to address specific societal questions….

Biden Administration Executive Actions: Scientific Integrity

On January 27, President Biden issued a Memorandum on Restoring Trust in Government Through Scientific Integrity and Evidence-Based Policymaking that states the Administration’s policy to “make evidence-based decisions guided by the best available science and data” and affirms that “scientific findings should never be distorted or influenced by political considerations.” The memorandum builds on and updates an Obama Administration Executive Order requiring federal agencies develop scientific integrity policies. President Biden’s memorandum establishes a Task Force on Scientific Integrity that will review existing scientific integrity policies and recommend improvements. It also sets more detailed requirements for what should be included in…

PCAST Holds Virtual Meeting, Swears in New Members from Academia

On June 30, the President’s Council of Advisors on Science and Technology (PCAST) held a virtual meeting during which two new members of PCAST were sworn in. Abraham “Avi” Loeb, Professor and Chair of the Department of Astronomy at Harvard University, and Daniela Rus, Director of the Computer Science and Artificial Intelligence Laboratory at the Massachusetts Institute of Technology, were sworn in after being nominated in April amid discussions that new PCAST nominees would represent academia given that representatives from industry have already been appointed (see previous COSSA coverage for more details). Much of the meeting was dedicated to discussing…

White House Announces Appointments for PCAST and NSB

On April 20, the White House announced the appointment of several individuals for key positions in the Administration including two seats on the President’s Council of Advisors on Science and Technology (PCAST) and four seats on the National Science Board (NSB), the advisory body to the National Science Foundation (NSF). This wave of nominations for PCAST follows an announcement from White House Office of Science and Technology Policy (OSTP) Director and PCAST Chair Kelvin Droegemeier that several future PCAST nominees would come from academia rather than industry (read previous COSSA coverage for more details). The two nominees for PCAST are:…

White House Reconstitutes President’s Council of Advisory on Science and Technology

On October 22, the Trump Administration issued an executive order reconstituting the President’s Council of Advisors on Science and Technology (PCAST). PCAST is comprised of experts from science and technology from outside the government who volunteer to advise the White House; it has not met since the Obama Administration. In addition to reconstituting the council, the President also appointed seven members to PCAST. The members primarily have backgrounds in the private sector: Dario Gill of IBM research, A.N. Sreeram of Dow Chemical, Sharon Hrynkow of Cyclo Therapeutics, H. Fisk Johnson of S.C. Johnson Inc., Catherine Bessant of Bank of America,…

PCAST Hears Interim Report on Precision Medicine Initiative

On May 15, the President’s Council of Advisors on Science and Technology (PCAST) received an interim report on the President’s proposed Precision Medicine Initiative (PMI). Opening the meeting, PCAST co-chair and director of the White House Office of Science and Technology Policy (OSTP) John Holdren discussed the ongoing budget process and the challenges associated with the FY 2016 budget. Despite these challenges, Holdren noted, there are a number of exciting initiatives in progress, including the Precision Medicine Initiative.


Past Newsletters



Browse 40 years of the COSSA Washington Update.